Sachem Head Capital Management LP Grows Holdings in Sotera Health Company $SHC

Sachem Head Capital Management LP increased its position in Sotera Health Company (NASDAQ:SHC) by 47.2% in the 4th quarter, HoldingsChannel reports. The fund owned 11,645,000 shares of the company’s stock after buying an additional 3,735,000 shares during the quarter. Sotera Health makes up about 4.8% of Sachem Head Capital Management LP’s holdings, making the stock its 11th largest holding. Sachem Head Capital Management LP’s holdings in Sotera Health were worth $205,418,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. IFP Advisors Inc increased its holdings in Sotera Health by 1,105.6% in the 4th quarter. IFP Advisors Inc now owns 1,495 shares of the company’s stock worth $26,000 after acquiring an additional 1,371 shares in the last quarter. Rothschild Investment LLC purchased a new stake in Sotera Health in the 4th quarter worth approximately $27,000. True Wealth Design LLC increased its holdings in Sotera Health by 389.3% in the 4th quarter. True Wealth Design LLC now owns 1,830 shares of the company’s stock worth $32,000 after acquiring an additional 1,456 shares in the last quarter. EverSource Wealth Advisors LLC increased its holdings in Sotera Health by 831.4% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 3,288 shares of the company’s stock worth $37,000 after acquiring an additional 2,935 shares in the last quarter. Finally, Eurizon Capital SGR S.p.A. purchased a new stake in Sotera Health in the 4th quarter worth approximately $40,000. 91.03% of the stock is owned by hedge funds and other institutional investors.

Sotera Health Stock Performance

SHC stock opened at $16.19 on Monday. Sotera Health Company has a 1-year low of $10.80 and a 1-year high of $19.85. The company has a debt-to-equity ratio of 3.56, a current ratio of 2.82 and a quick ratio of 2.54. The company has a market capitalization of $4.62 billion, a price-to-earnings ratio of 39.49 and a beta of 1.79. The business has a 50 day simple moving average of $15.61 and a two-hundred day simple moving average of $16.38.

Sotera Health (NASDAQ:SHC) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The business had revenue of $280.05 million during the quarter, compared to the consensus estimate of $270.78 million. During the same period in the prior year, the company posted $0.14 EPS. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. Research analysts anticipate that Sotera Health Company will post 0.86 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently issued reports on SHC. Citigroup increased their target price on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 target price for the company. Wall Street Zen lowered shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Weiss Ratings lowered shares of Sotera Health from a “hold (c)” rating to a “hold (c-)” rating in a report on Thursday, May 21st. Finally, Piper Sandler reissued an “overweight” rating and issued a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Eight analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $20.29.

Insiders Place Their Bets

In other news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total transaction of $193,194,516.17. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 15.36% of the stock is owned by insiders.

Sotera Health Company Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.